Research ArticleArticle
Metabolism of a 5HT6 antagonist, 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-benzo[d]imidazole (SAM-760): impact of sulfonamide metabolism on diminution of a ketoconazole mediated clinical drug-drug interaction
Aarti Sawant-Basak, R. Scott Obach, Angela C Doran, Peter Lockwood, Klaas Schildknegt, Hongying Gao, Jessica Mancuso, Susanna Tse and Tom Comery
Drug Metabolism and Disposition April 25, 2018, dmd.118.080457; DOI: https://doi.org/10.1124/dmd.118.080457
Aarti Sawant-Basak
1 Pfizer Inc.;
R. Scott Obach
2 Pfizer Global Research and Development;
Angela C Doran
3 Pfizer;
Peter Lockwood
3 Pfizer;
Klaas Schildknegt
3 Pfizer;
Hongying Gao
4 Innovobioanalysis;
Jessica Mancuso
3 Pfizer;
Susanna Tse
3 Pfizer;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Metabolism of a 5HT6 antagonist, 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-benzo[d]imidazole (SAM-760): impact of sulfonamide metabolism on diminution of a ketoconazole mediated clinical drug-drug interaction
Aarti Sawant-Basak, R. Scott Obach, Angela C Doran, Peter Lockwood, Klaas Schildknegt, Hongying Gao, Jessica Mancuso, Susanna Tse and Tom Comery
Drug Metabolism and Disposition April 25, 2018, dmd.118.080457; DOI: https://doi.org/10.1124/dmd.118.080457
Research ArticleArticle
Metabolism of a 5HT6 antagonist, 2-methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-benzo[d]imidazole (SAM-760): impact of sulfonamide metabolism on diminution of a ketoconazole mediated clinical drug-drug interaction
Aarti Sawant-Basak, R. Scott Obach, Angela C Doran, Peter Lockwood, Klaas Schildknegt, Hongying Gao, Jessica Mancuso, Susanna Tse and Tom Comery
Drug Metabolism and Disposition April 25, 2018, dmd.118.080457; DOI: https://doi.org/10.1124/dmd.118.080457
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement